Concepta opens new laboratory at Colworth Park

The AIM-traded firm said the new laboratory opening is in line with its strategy of increasing its operational capacity and economies of scale as it moves towards launching its My Lotus product for unexplained infertility into China in H2 2016 and, following CE marking, into the UK and Europe in 2017.

It said the “state of the art” laboratory will house four employees in research and development, and another two employees in quality assurance.

Additionally, a separate area for assembly can accommodate a further ten people producing testing strips for Concepta's 'My Lotus' meter, the board explained.

Aside from manufacture, assembly and testing, the lab will primarily be used as a research and development hub for My Lotus product enhancements and new product development.

“Following our highly successful AIM listing in July 2016, this new laboratory is a key part of the company's growth strategy and extends both its capacity and capabilities as we begin the process of launching our proprietary product into China prior to a European launch in 2017,” said CEO Erik Henau.

“Concepta's research team will be working in the new lab effective immediately to accelerate new product development, both within our core business area of fertility as well as other areas in the wider mobile health space.

“We look forward to updating the market on these exciting developments in due course.”